2
↑2
↓0
—0
Evidence suggests Psilocybin mayincreaseTherapeutic outcomes.
1 studies (2 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
2 of 2
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| psilocybin | Increases - greater mediating effect for subjective effects mediating therapeutic outcomes | therapeutic outcomes | Human | patients with depression or SUD | Not available | Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.cited 2× |
| psilocybin | Increases - greater mediating effect | therapeutic outcomes | Human | patients with depression | Not available | Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.cited 2× |